People
Adaptimmune announced several changes to its executive leadership team. Perhaps the biggest news is that Rafael Amado, president of R&D, is leaving the company “to pursue other opportunities.”
Attracting Top Talent Will Enable VMS to Continue Expanding Its Clinical Nurse Educator Programs to Help More Patients Served by the Biopharma Industry
Arvinas, Inc., a biotechnology company creating a new class of drugs based on targeted protein degradation, announced the appointment of Ronald Peck, M.D. to the newly created position of Chief Medical Officer.
Ruben Echandy Brings More Than 20 Years of Experience to the Role
Silence Therapeutics, PLC is pleased to announce that further to the announcements on 18 July 2019 detailing the Company’s collaboration with and equity investment by Mallinckrodt plc, Steven Romano, MD, has joined the Board of Silence as a Non-Executive Director.
A recent study published in the American Journal of Human Genetics found that female scientists asked fewer questions than expected at scientific conferences. It doesn’t appear to have much to do with the percentage of women in the sciences, but something cultural or internal.
The Tribune India has recently announced that the Department of Biotechnology will be training “unemployed youth in tools and techniques in the area of biotechnology within a period of three years.”
Taking over the reins of the company will be Vertex’s Chief Medical Officer Reshma Kewalramani. She will assume the role of president and CEO and also take a seat on the board of directors, Vertex announced.
ASLAN Pharmaceuticals, a clinical-stage oncology and immunology focused biopharma company, announced that Andrew Howden has been elected as non-executive Chairman of the Board.
Biotech and pharma companies bolster their executive leadership and boards of directors with this week’s appointments.
PRESS RELEASES